chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to a 57 year old female patient. Patients medical history, drug reactions and allergies were reported as none. On 18-MAR-2014, the patient was vaccinated with ZOSTAVAX vial, strength 19400 plaque-forming units (PFU), (lot number and expiry date were unspecified), dose 0.65 ml, subcutaneous. Concomitant therapy was reported as none. Approximately in March 2014, the patient experienced tenderness in one breast on the outer aspect of the breast. The patient called pharmacist and stated that her breast felt like when someone became pregnant and her breasts get tender, except for it was only in one breast. No treatment was given for the event. No lab diagnostics studies were performed. No product quality complaint was involved. The outcome of tenderness in breast was reported as not recovered. The reporters causality assessment for the event tenderness in one breast with the therapy of ZOSTAVAX was not reported. No further information provided. Additional information has been requested.
developed a COVID-19 infection/positive COVID-19 test with symptoms; This is a spontaneous report from a contactable consumer (patient). A 51-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL8982), intramuscular on right arm on 16Jan2021 13:00 at single dose for COVID-19 vaccination. Medical history was none. There were no concomitant medications. The patient stated that after the first dose of the Pfizer Covid-19 vaccine he got sick and developed a COVID-19 infection. He got the first shot on 16Jan2021. He got sick a few days later on 20Jan2021 and he thought it may have been a sinus infection or side effects to the vaccine. He got tested for Covid-19 last Monday 25Jan2021 and it came back positive. He clarified that he started feeling like he had a sinus infection, and reported congestion, feeling run down, and cold symptoms. He was still experiencing congestion and a occasional headaches. The sick was recovering. The events did not require a visit to Emergency Room or Physician Office. He was scheduled to get the second dose tomorrow 03Feb2021 and he was over the quarantine, wanted to know if he is still able to get the second dose. The writing on the sticker on his vaccination card was very little. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer vaccine. The patient did not receive any other vaccines within 4 weeks prior to vaccinations. The report was reported as non-serious. The outcome of the event was unknown.
I had the shot given this morning around 10:15 about 3:30 PM I cold tell my blood pressure was up so started monitoring  159/86 took at 4 PM 174/89 then at 430 171/102, CNP my family "Dr." had wrote a script for 7 Clonidine 0.1 mg pills for in case of emergency of my BP going to 170 as it had once in her office. I took the 1 pill and called to her. Laid down and rested no tv, no music and within an hour it was back down first 146/76 then hour later 134/62.
On May 28th 2021 I began to develop a photosensitive rash on my upper arms and upper thighs. 1 week later I began to experience severe joint pain in my knees and hips. Since May 28th I have been getting ulcers in my mouth as well. I have also felt extremely fatigued along with brain fog.  This is all out of the ordinary for me.
Initial report was received from a health care professional on 03 May 2012. A 13-year-old male patient had received a dose one intramuscular injection of ADACEL, lot number C4030AA, and a dose one intramuscular injection of MENACTRA, lot number U4249AA on 09 January 2012. On 30 April 2012, the patient was diagnosed with pertussis by DNA PCR nasal aspirate. The patient was treated with "Zythromycin Z-PAC." The patient also developed a cough and was treated early in the paroxysmal stage. The patient had no illness at the time of vaccination. The patient had a medical history of seasonal/environmental allergies and received allergy shots. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: None.
Fever, vomiting, moderated dehydr seen in office 12/2/10 tx with ZOFRAN, oral rehydration, improved by 12/3/10.
very bad body aches; a lot of pain in the arm of the injection; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (very bad body aches), PAIN IN EXTREMITY (a lot of pain in the arm of the injection) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (very bad body aches), PAIN IN EXTREMITY (a lot of pain in the arm of the injection) and HEADACHE (headache). At the time of the report, PAIN (very bad body aches), PAIN IN EXTREMITY (a lot of pain in the arm of the injection) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.  No treatment information was provided.
Visited Dr. 02/06/2015. Swollen, red and painful area of injection site about the size of a baseball. Dr. office concluded cellulitis and prescribed prednisone and BACTRIM.
Was to start 6th grade 8/24/2016 received vaccine 8/16/2016. She was happy healthy athletic in gymnastics able to eat anything she wanted. after started gastrointestinal issues (chronic stomachaches, diarrhea, nausea) she has joint pain, rashes, hormonal issues, food allergies and sensitivities, anxiety, POTS syndrome, lots of dizziness and shortness of breath.  Saw many doctors with no answers before making the connection.
PAIN TO LOWER BACK AND INTO RIGHT THIGH, MUSCLES ACHES, HEADACHE
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 35-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 10-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vaccine was stored in freezer, one to two vials were taken out and placed in the fridge each day as needed. No concomitant medications were reported  No treatment was given.
Information has been received from a registered nurse referring to multiple unspecified patients of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies were not reported. On unknown dates, the patients were vaccinated with doses of improperly stored ROTATEQ (lot # L039141 with expiration date 16-AUG-2017 and lot # M004883 with expiration date 02-OCT-2017; dose was not reported) orally. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's medical history, drug reactions or allergies and concurrent conditions were not reported. On 13-OCT-2015, the patient was vaccinated with a dose of improperly store RECOMBIVAX HB, lot number L016427, expiration date 13-APR-2017, (dose, route and anatomical location were not reported). No adverse effect was reported. There was no concomitant medication reported. This is one of several reports from the same source. Additional information has been requested.
Patient was a healthy (not overweight and no known medical issues), functioning man that worked out regularly, excelled in his career and was always active. 3 days after Patient received his 2nd Covid vaccine he started with severe back pain, that led into slurred speech,  breathing issues (difficulty breathing at night especially-started to use a C-pap machine), vision issues- double vision, became unsteady on his feet, which then resulted in on and off paralysis, loss of bowel and bladder control. It appeared that he had a stroke, but they could not find any evidence. They also found a cancerous tumor on his kidney, which was removed surgically and he did not need additional treatment. However, he did later have issues with his kidney leaking fluid and had a tube placed in his back to drain the fluid. He was hospitalized 3-4 times, went to a skilled nursing facility twice. Received OT and PT to assist in gaining any functionality back. He was tested for MS, ALS, various other diseases  and autoimmune disorders and was finally given a diagnosis of Transverse Myelitis and then auto immune encephalomyelitis. He recently received an infusion of rituximab in October 2022.  His suffering was endless and he ultimately passed away on 11/9/22, we are awaiting results of the autopsy because cause of death was not obvious.
Immediately after injection i became nauseous followed by dry heaving, head fog, and aggressive corse tremors
I got so sick from the flu shot; chills; Initial information regarding an unsolicited valid non-serious case received from a consumer(patient) via social media on 30-Oct-2020.  This case involves a patient of unknown demographics who got so sick from the flu shot (Illness) and chill for 2 days (Chills), while he/she received Influenza Vaccine.  The patient's medical history included as pacemaker user. The patient's medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date unknown) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date (latency unknown) after the administration of suspect the patient had got so sick from the flu shot (Illness) and chill for 2 days (Chills).  No laboratory test was reported.  It was not reported if the patient received a corrective treatment.  The outcome was unknown for both the events.  There will be no information available on the batch number for this case.
I noticed I was not getting rid of any headaches or migraines and my menstruation was not there. I had hot flashes extreme exhaustion and I was unable to sleep at night all of these symptoms are very similar to symptoms of menopause. After being tested, it was concluded I was not going through menopause. After 90 days the symptoms went away and everything is pretty much back to normal. I still have occasional headaches that may be due to allergies. I also noticed my sense of smell has been impacted I can't smell roses or other floral scents. I am still experiencing mild levels of tiredness from time to time.
Anaphylactic Reaction, given epi pen at clinic and transferred to hospital by ambulance, had breathing tube inserted because swelling in throat and mouth would go down with epinephrine treatments, stayed in ICU for 4 days with epinephrine, Benadryl, and steroid treatments. Breathing tube was removed on third day in hospital.
Seven year old male patient was at the clinic with his father. He was here for the Pfizer peds second doses. The writer went to pick up the pre-drawn vaccination. The writer communicated with the team lead.  The team lead was middle of drawing vaccines. The team lead pointed at the 1 inch vaccine. It was a  baby Moderna vaccine. The 7 year old received the second baby Moderna vaccine instead of the peds Pfizer dose. The POD managers are aware. Child had no adverse effects. The child was observed for 30 mins post vaccination. Checked with CDC for the protocol for this event.  the CDC advised to administer the correct dose. Family has already left the facility after 30 mins. The client did not receive  any additional vaccines.
Patient developed stroke like symptoms one week after receiving the flu vaccine. Was evaluated in the ER and diagnosed with Bell's Palsy. Symptoms continue at the time of this report.
3rd day became very dizzy, dry heaves.  Dizziness continues for 2 weeks now, gradually improving in intensity and frequency.
Arm pain, swelling at injection site, pain down through fingertips and up through neck and ear, muscle spasms in back, knee and calf, mild fever
Initial unsolicited report received from a pharmacist on 9 October 2015. This case involves a female patient (age not reported) who was vaccinated with an intramuscular dose of FLUZONE HD (batch number UI486AA, expiry date 24 May 2016, site of administration not reported) on 9 October 2015. The patient's pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) was reported as none, Illness at time of vaccination was none and concomitant medications were not reported. On 9 October 2015, few minutes after the vaccination the patient's right deltoid swelled up like a goose egg. No other symptoms reported. Laboratory investigations were reported as none and corrective treatments were not reported. The final outcome was reported as not recovered. Documents held by sender: none Follow-up information received from a pharmacist on 30 November 2015. The patient received FLUZONE HD vaccine in right arm on 9 October 2015. It was reported that, patient waited approximately 15 minutes and swelling went down to almost normal in that time, no other outcome seen or reported. Documents held by sender: none.
Patient states that 5 days after receiving her shingrix vaccine she developed rash and itching that moved from one part of the body to other including her legs and arms.  She took  benadryl 25mg tablets that helped her control rash temporarily but rash came back the next day. She states that she also suffers from eczema and this rash could be because of eczema. She notified her primary doctor.
pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (binge, twice a week six drinks) from 01-Jan-2010 to 01-May-2014 and Drug abuse (daily for a year 30-90 mg daily) from 01-Jan-2013 to 01-May-2014. Concurrent medical conditions included Allergy to antibiotic. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 01-May-2020 to an unknown date for Pregnancy.    On 21-Jan-2021 at 10:50 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 17-Jun-2020 and the estimated date of delivery was 05-Apr-2021. On 21-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 21-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jul-2020, Pregnancy test: positive (Positive) positive. On 30-Nov-2020, Ultrasound scan: normal (normal) Normal. On 07-Jan-2021, Glucose tolerance test: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. Patient estimated date of conception was on 13-jul-2020 patient under gone anotomy scan on 2-nov-2020 and 30-nov-2020 results are unknown
2 days after the shot they had the usual pain where the got the shot and it disappeared; some stuffiness that changes between the nostrils; minor sore throat; This spontaneous case was reported by a patient and describes the occurrence of NASAL CONGESTION (some stuffiness that changes between the nostrils), OROPHARYNGEAL PAIN (minor sore throat) and VACCINATION SITE PAIN (2 days after the shot they had the usual pain where the got the shot and it disappeared) in a 69-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 01-Nov-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 03-Nov-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced VACCINATION SITE PAIN (2 days after the shot they had the usual pain where the got the shot and it disappeared). In November 2023, the patient experienced NASAL CONGESTION (some stuffiness that changes between the nostrils) and OROPHARYNGEAL PAIN (minor sore throat). At the time of the report, NASAL CONGESTION (some stuffiness that changes between the nostrils) and OROPHARYNGEAL PAIN (minor sore throat) had not resolved and VACCINATION SITE PAIN (2 days after the shot they had the usual pain where the got the shot and it disappeared) had resolved.            Patient had no allergies, no medical conditions and not on any medications.  Patient had all Moderna vaccine.  It was reported that patient got a minor sore throat and some stuffiness that changes between the nostrils. 2 days after the shot they had the usual pain where the got the shot and it disappeared. Patient got the shot 2 to 3 weeks ago. patient did not do anything for a week and then went somewhere days after. Not gotten tested yet for covid. No other vaccines received within 4 weeks.   No treatment medication information was provided.   Reporter did not allow further contact
Fever of 99.6 degrees for 6 hours, followed by GI pain for 2 hours. Extreme fatigue for 24 hours, headache the 2nd day for 2 hours.
Patient woke up the night of the shot and experienced let crams, she was gasping for air, and had shortness of breath. She also experienced leg cramps. This lasted for 3 days.
Covid Toes - Chilblains -- according to Dr.  Dr. instructed me to report my swollen, purple toes on VAERS.
Immunization Admin. COVID-19 30mcg/0.3mL Dosage 1st Dose Pfizer (Z23); ­COVID-19 Vaccine, 30 Mcg/0.3mL Dosage, Diluent Reconstituted, For Intramuscular (Z23) (IM injection) Manufacturer Pfizer Lot EL3249 Expiring 05/01/2021 ­   Vaccination received on 1-12-21, left deltoid.  She had localized stinging in left proximal lateral arm for first 12-24 hrs; then itchy welt at injection site and nearby separate itchy small area on proximal lateral arm on 1-13-21. Progressive increase in size/persistent itching. Evaluated on 1-19-21.  Afebrile. There is 2x2.5 cm mildly tender, slightly indurated nodularity surrounded by 10x9 cm confluent erythema demarcated by pen, which has extended to 12x9.5 cm in widest margins. Confluent erythema is slightly warm to touch, nontender, nonindurated, no red streaks. No left axillary adenopathy. Treated with antihistamines.
Patient reports that she received COVID Booster on 9/29/2021. States low grade temp (99) for a few days, mild pain at injection site of left deltoid, body aches and headaches for last 3 days.  Advised to call PCP for appointment. Patient verbalized understanding.
This spontaneous report as received from a Licensed Practical Nurse refers to an unspecified number of patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown date between 12-JAN-2015 and 05-JUL-2015, the unspecified number of patients were vaccinated with ROTATEQ orally, lot # K006805 exp. 24-MAR-2016, lot # K009753 exp. 28-APR-2016, lot # K010222 exp. 12-MAY-2016, lot # K011948 exp. 07-JUN-2016 (dose, route of administration not reported). The ROTATEQ was improperly stored. There was no adverse effects reported. Additional information has been requested. This is one of several reports from the same reporter.
HAD SOME TEMPORARY  ARM SORENESS TO VACCINE  SYMPTOMS OF ADVERSE EVENT BEGAN ON 10-31-22, AND LASTED AROUND THREE WEEKS BEFORE GOING TO URGENT CARE.  SYMPTOMS:  HARD CHILLS, INTERMITTENT FEVER, EXTREME FATIGUE, - AT URGENT CARE, LUNG XRAY AND THEN CT SCAN SHOWED LUNG NODULES & ENLARGED LYMPH NODE.  SENT TO PULMONOLOGY, BIOPSY SHOWED HISTOPLASMOSIS INFECTION, SENT TO INFECTIOUS DISEASE DOCTOR WHO STARTED ME ON ITRACONAZOLE (ANTI-FUNGAL MEDICATION)
Pt recvd vax 8JAN93 & in the afternon of same day began to exp a nagging h/a & mild dizziness;  has cont to work; did not report to ER or physicians office;
Patient called the clinic and she informed me that her left arm is severely swollen and painful. She explained that the pain and swollen started only after she received the shingles vaccine.
No additional AE reported.; VARIVAX was administered to a patient after a prior temperature excursion occured, but before the most recent temperature excursion.; This spontaneous report has been received from a nurse and refers to patient of unknown age and gender.  The patient's pertinent medical history, current conditions, previous drug reactions or allergies and concomitant medications were not provided.   On 08-JUL-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection, at dose 0.5 ml, lot number U025205 has been verified to be valid, expiration date 13-AUG-2023 for prophylaxis (strength, route of administration and anatomical location of vaccination were not provided) that underwent a temperature excursion of 9.4 Fahrenheit degrees (reported as the highest temperature) for 48 hours (product storage error). No additional adverse events were reported. There was a previous temperature excursion of 32.2 Fahrenheit degrees for 5 hours.
Pt presented to clinic 2 days after vaccination c/o local reaction. Injection site has notable redness, warmth, induration approx 4 cm in diameter. Pt denies rash/difficulty breathing at time of immunization. No systemic symptoms at present time. Pt reports improvement over the last 24 hrs. Pt took ibuprofen last night. Advised pt, can continue to take ibuprofen for pain, apply cold compress to affected area as needed. Informed local reactions are within normal expected side effects, should resolve in the next 1-2 days, call clinic for new or worsening sxs. Pt verbalized understanding.